Shares have seen increased volatility despite the company gaining its first-ever marketing approval recently.
If you're looking to kick back and build wealth from stock gains and income payments, then consider International Paper, Kinder Morgan, and A.O. Smith.
The genetic testing leader may never return to its former glory.
The Lucky Friday mine strike has significantly impacted operations this year. Is management's handling of the issue to blame?
One in four of the company's shares is currently being shorted, but bears appear to be wrong about this pharma stock.
Halozyme Therapeutics, FMC Corp., and Braskem all have major opportunities in front of them that could lead to outsize returns.
Investors shouldn't be surprised if Tesla, Northern Dynasty Minerals, and CF Industries head lower.
It's probably best to stay away from Ziopharm, Civeo Corp, and Intrepid Potash.
Bargain-hunting investors may be snooping around Tahoe Resources, Barrick Gold, and Goldcorp. Are any of these gold stocks buys right now?
A certain group of Wall Street analysts readjusted their views on the company's shares.
Intrexon has been touting the potential of a new technology platform to alter global chemical production.
Some stocks just aren't the right fit for some investors.
The small-cap biopharma company announced the pricing of a new share offering.
There are numerous reasons to be bullish on this gold stock.
These smaller companies hold big potential.
Bitcoin may grab most of the headlines, but it's far from the only cryptocurrency or cryptoasset. These others may even be more useful in the long run.
Most of the uranium miner's supply contracts expire by 2021. What happens after that?
A lead product candidate failed in a phase 2/3 trial, but shares have recovered to a smaller loss.
There's a lot of talk of gloom and doom about Uncle Sam's trade deficit, but a significant rebalancing is on the horizon.